Home Frontmatter
Article Publicly Available

Frontmatter

Published/Copyright: May 28, 2021

Published Online: 2021-05-28
Published in Print: 2021-06-25

©2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. Provocative growth hormone testing in children: how did we get here and where do we go now?
  4. Original Articles
  5. Mental and somatic health in university students with type 1 diabetes: new results from DiaSHoT18, a cross sectional national health and well-being survey
  6. Prevalence of elevated liver enzymes and their association with type 2 diabetes risk factors in children
  7. What is the relationship between obesity and new circadian rhythm parameters in Turkish children and adolescents? A case-control study
  8. Body fat distribution in trunk and legs are associated with cardiometabolic risk clustering among Chinese adolescents aged 10–18 years old
  9. Is overweight/obesity a risk factor for atopic allergic disease in prepubertal children? A case–control study
  10. Importance of individualizing treatment decisions in girls with central precocious puberty when initiating treatment after age 7 years or continuing beyond a chronological age of 10 years or a bone age of 12 years
  11. Blood pressure dynamics after pubertal suppression with gonadotropin-releasing hormone analogs followed by estradiol treatment in transgender female adolescents: a pilot study
  12. Levels of physical activity and barriers to sport participation in young people with gender dysphoria
  13. Serum sclerostin concentration is associated with specific adipose, muscle and bone tissue markers in lean adolescent females with increased physical activity
  14. Validation of a continuous measure of cardiometabolic risk among adolescents
  15. Clinical characteristics and molecular genetic analysis of a cohort with idiopathic congenital hypogonadism
  16. The genetics and clinical manifestations of patients with vitamin D dependent rickets type 1A
  17. Switching from conventional therapy to burosumab injection has the potential to prevent nephrocalcinosis in patients with X-linked hypophosphatemic rickets
  18. Case Reports
  19. Asymptomatic pituitary apoplexy induced by corticotropin-releasing hormone in a 14 year-old girl with Cushing’s disease
  20. Two patients from Turkey with a novel variant in the GM2A gene and review of the literature
  21. Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate
  22. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-frontmatter6/html
Scroll to top button